Conflicts of Interest & Advertising
How we make money — and how we keep that separate from how we grade evidence.
Last updated: July 11, 2026
A site that grades health compounds has an obvious conflict risk: the incentive to be generous to whatever it can sell. We manage that by keeping a hard wall between what we earn from and how we grade, and by disclosing the relationships that could look like a conflict even when they aren't.
How Synptide is funded
Synptide's public site supports a subscription app for private tracking. Our commercial interest is in the tracking product, not in selling, promoting, or steering you toward any specific compound. We do not sell peptides, medications, or supplements.
The editorial wall
- Evidence grades are assigned from the literature, never adjusted to favor a product, sponsor, or affiliate.
- No advertiser or partner previews, approves, or edits a compound grade, a comparison verdict, or a safety statement.
- "Track this in Synptide" calls-to-action are clearly our own product and are never disguised as an evidence recommendation.
Affiliate and advertising disclosure
Where a page contains an affiliate link or sponsored placement, it is disclosed on that page. The presence of such a link never changes how a compound is graded or described. Full terms are in ouraffiliate disclosure.
Author and reviewer conflicts
Anyone who writes or reviews evidence-sensitive content discloses relevant financial or professional interests. Where a named reviewer has a relevant conflict, it is noted on the pages they reviewed. We do not fabricate reviewers or credentials — see our review process.
Reporting a concern
If you believe a commercial interest has influenced our editorial content, email [email protected]. We take it seriously.